Interested in promotions? | Click here >>
Human Stromal Cell-derived Factor 1β/CXCL12 (hSDF1β)
Growth Factors and Cytokines

Human Stromal Cell-derived Factor 1β/CXCL12 (hSDF1β) #5712

Citations (0)
Human Stromal Cell-derived Factor 1β/CXCL12 (hSDF1β): Image 1
hSDF1β-induced migration of NK-92 cells was assessed. NK-92 cells were incubated in a 96-well transwell plate with increasing concentrations of hSDF1β in the bottom chamber. After 2 hours, the number of NK-92 cells that migrated to the bottom chamber of the transwell was quantified by measuring DNA content using a fluorescent dye.
Human Stromal Cell-derived Factor 1β/CXCL12 (hSDF1β): Image 2
The purity of recombinant hSDF1β was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hSDF1β and staining overnight with Coomassie Blue.


With carrier: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl and 20 μg BSA per 1 μg hSDF1β. Carrier free: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl.


Stable in lyophilized state at 4°C for 1 year after receipt. Sterile stock solutions reconstituted with carrier protein are stable at 4°C for 2 months and at -20°C for 6 months. Avoid repeated freeze-thaw cycles. Maintain sterility. Storage at -20°C should be in a manual defrost freezer.

Product Description

MW (kDa) 9
Purity >98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hSDF1β. All lots are greater than 98% pure.
Endotoxin Less than 0.01 ng endotoxin/1 μg hSDF1β.
Activity The activity of hSDF1β was determined using an NK-92 cell migration assay. The ED50 of each lot is between 0.1-0.3 µg/ml.
Molecular Formula Recombinant hSDF1β has a Met on the amino terminus and has a calculated MW of 8,657. DTT-reduced protein migrates as an 8 kDa polypeptide and non-reduced protein migrates as a 12 kDa polypeptide. The expected amino-terminal MKPVS of recombinant hSDF1β was verified by amino acid sequencing.

Source / Purification

Recombinant human SDF1β (hSDF1β) Lys22-Met93 (Accession #NP_000600) was produced in E. coli at Cell Signaling Technology.


SDF1, also known as CXCL12 and PBSF, is an 8 kDa member of the CXC family of chemokines (1). SDF1 is highly conserved across species and the human protein differs from mouse by only one conserved amino acid substitution (2). SDF1α and SDF1β are splice variants which are identical with regard to amino acid sequence except for an additional 4 amino acids on the carboxy terminus of SDF1β (3). Both SDF1 isoforms binds to the G protein-coupled receptor, CXCR4 (4). SDF1β is a potent lymphocyte chemoattractant (5). SDF1/CXCR4 signaling is required for B cell lymphopoiesis and myelopoiesis (6,7). While CXCR4 signaling plays a key role in breast cancer metastasis, increased SDF1 expression in breast cancer may be a prognostic indicator of overall survival (8).
  1. Zlotnik, A. and Yoshie, O. (2000) Immunity 12, 121-7.
  2. Shirozu, M. et al. (1995) Genomics 28, 495-500.
  3. Tashiro, K. et al. (1993) Science 261, 600-3.
  4. Roland, J. et al. (2003) Blood 101, 399-406.
  5. Bleul, C.C. et al. (1996) J Exp Med 184, 1101-9.
  6. Ma, Q. et al. (1998) Proc Natl Acad Sci U S A 95, 9448-53.
  7. Nagasawa, T. et al. (1996) Nature 382, 635-8.
  8. Mirisola, V. et al. (2009) Eur J Cancer 45, 2579-87.

Pathways & Proteins

Explore pathways + proteins related to this product.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST's products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST's Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
Inquiry Info.# 5712